[Molecular mechanisms of DNA recognition and function by bioactive compounds]

Area of Science:

• Molecular pharmacology
• Biochemistry
• Medicinal chemistry

Context:

• Bioactive compounds like bleomycin, enediyne antibiotics, and zinc finger proteins are crucial in pharmaceutical research.
• Bleomycin's antitumor activity is linked to its DNA cleavage mechanism, involving a bleomycin-iron complex similar to cytochrome P450's dioxygen activation.
• Enediyne antibiotics, such as C-1027, exhibit potent anticancer properties through unique chemical structures and interactions with DNA and RNA.

Purpose:

• To elucidate the molecular mechanisms of DNA recognition and functional expression by bleomycin, enediyne antibiotics, and zinc finger proteins.
• To investigate the DNA cleavage mechanism of bleomycin and its iron complex.
• To understand the interaction of enediyne antibiotic C-1027 with DNA and RNA, and its drug delivery system.
• To explore the creation and function of artificial zinc finger proteins for therapeutic applications.

Summary:

• Bleomycin-iron complex activates dioxygen, leading to site-specific DNA cleavage, contributing to its anticancer effect.
• Enediyne antibiotic C-1027 interacts with DNA and RNA via its chromophore and apoprotein, providing insights into its biological action and delivery.
• Artificial zinc finger proteins, including His4-type, are engineered for novel functions like DNA cleavage and binding, showing potential in gene therapy.

Impact:

• The findings provide a molecular basis for understanding the action of bleomycin and enediyne antibiotics, aiding in the design of new anticancer agents.
• The study highlights the potential of RNA as a target for enediyne antibiotics.
• Engineered zinc finger proteins offer promising tools for genetic engineering and gene therapeutic applications.